by Jody Ranck | August 20, 2015

Emergence of Medicine-as-a-Service (Beyond the Pill)

The move to Value Based Care (VBC) is changing the relationships that pharma has historically had with both payers and providers. The growing chronic disease burden, rise of digital health and commoditization of many drug-disease areas is forcing a rethinking of the underlying pharmaceutical (pharma) business model.